Human lipocin/visFatin ELISA research kit,

Reagent Code: #249200

blur_circular Chemical Specifications

inventory_2 Storage & Handling
Storage 2-8°C

description Product Description

Used in biomedical research to measure visfatin (also known as lipocalin-2 or nicotinamide phosphoribosyltransferase) levels in human biological samples such as serum, plasma, and cell culture supernatants. This ELISA kit enables researchers to study the role of visfatin in metabolic regulation, insulin signaling, inflammation, and obesity-related diseases. It is commonly applied in clinical studies investigating type 2 diabetes, cardiovascular conditions, and metabolic syndrome. The assay provides a quantitative and sensitive method to monitor changes in visfatin concentration under experimental or pathological conditions, supporting both basic science and translational research.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 48T/EA
10-20 days ฿15,390.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Human lipocin/visFatin ELISA research kit,
No image available
Used in biomedical research to measure visfatin (also known as lipocalin-2 or nicotinamide phosphoribosyltransferase) levels in human biological samples such as serum, plasma, and cell culture supernatants. This ELISA kit enables researchers to study the role of visfatin in metabolic regulation, insulin signaling, inflammation, and obesity-related diseases. It is commonly applied in clinical studies investigating type 2 diabetes, cardiovascular conditions, and metabolic syndrome. The assay provides a quantitative and sensitive method to monitor changes in visfatin concentration under experimental or pathological conditions, supporting both basic science and translational research.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...